John W McGillicuddy, M.D.

Accepting New Patients

Accepting New Patients

Provider Image

New Patients

843-792-6100 843-792-6100

Returning Patients

843-792-6100 843-792-6100

Degree M.D.
School University of Michigan Medical School
Residency
  • University of Michigan
Fellowship
  • Medical University of South Carolina
Board Certification
  • American Board of Surgery
Specialties
  • Transplant Surgery
Clinical Interests
  • Liver transplant
  • Kidney transplant
  • Pancreas transplant
  • Chronic liver disease
  • Liver failure
  • Liver masses
  • Liver lesions
Accepts New Patients Yes

New Patients

843-792-6100 843-792-6100

Returning Patients

843-792-6100 843-792-6100

Locations

Rutledge Tower
135 Rutledge Avenue
Charleston, SC 29425
Map & Directions
 

Biography

John W. McGillicuddy, M.D., FACS, received his undergraduate degree in Molecular Biology from the University of Michigan in Ann Arbor, Michigan, graduating cum laude and inducted into Phi Beta Kappa for outstanding academic achievement.

Dr. McGillicuddy completed medical school at the University of Michigan where he was inducted into Alpha Omega Alpha for outstanding academic achievement. He completed his general surgery residency and Extra-coporeal Membrane Oxygenation (ECMO) fellowship and critical care fellowships at the University of Michigan before completing an abdominal transplant surgery fellowship at the Medical University of South Carolina.

Dr. McGillicuddy specializes in the management of end-stage liver and end-stage renal disease, including the evaluation and selection of patients for liver or kidney transplantation. He has a particular interest in the management and surgical treatment of benign and malignant liver lesions including hepatocellular carcinoma, cholangiocarcinoma, metastatic liver tumors, hepatic adenoma, focal nodular hyperplasia, hepatic hemangioma, and hepatic cysts.

Dr. McGillicuddy also performs a wide variety of general surgical procedures in patients with end-stage organ disease.

Dr. McGillicuddy's research interest lies in the use of mobile health technology (mHealth) to improve the health and well being of transplant patients.